![Ian Mark Buckley-Golder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian Mark Buckley-Golder
Presidente presso Cascade Fund Management Ltd.
Provenienza dei contatti di primo grado di Ian Mark Buckley-Golder
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Cascade Fund Management Ltd.
2
| Subsidiary | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ian Mark Buckley-Golder tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Piramed Ltd.
![]() Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Director/Board Member | |
VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member | |
The Institute of Cancer Research: Royal Cancer Hospital
![]() The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
THERACRYF PLC | Medical/Nursing Services | Chairman | |
BTG | Pharmaceuticals: Major | Director/Board Member | |
ALLIANZ TECHNOLOGY TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
SOURCE BIOSCIENCE PLC | Medical/Nursing Services | Director/Board Member | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
Spectrum Ltd.
![]() Spectrum Ltd. Electronic Production EquipmentElectronic Technology Spectrum Ltd., engages in manufacturing accessories for video games. The company is headquartered in Jessup, MD. | Electronic Production Equipment | Director/Board Member | |
Cancer Research Ventures Ltd.
![]() Cancer Research Ventures Ltd. Pharmaceuticals: GenericHealth Technology Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom. | Pharmaceuticals: Generic | Chief Executive Officer | |
Excalibur Fund Managers Ltd.
![]() Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Cancer Research Technology Ltd.
![]() Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer | |
Innovata Ltd.
![]() Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
International Institute for Management Development | College/University | Masters Business Admin | |
University of Aston | College/University | Undergraduate Degree | |
Lifearc
![]() Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
The UK Innovation & Science Seed Fund LP
![]() The UK Innovation & Science Seed Fund LP Investment ManagersFinance The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions. | Investment Managers | Chairman | |
Paras Ltd.
![]() Paras Ltd. Miscellaneous Commercial ServicesCommercial Services Paras Ltd. provides information management and strategy consultancy services to the energy sector. The company was founded by Hamish Angus Munro Wilson in 1993 and is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cizzle Biotechnology Ltd.
![]() Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Biotechnology | Chairman | |
ADC Products (UK) Ltd.
![]() ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder | |
Celltech Ltd.
![]() Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Xenva Ltd.
![]() Xenva Ltd. Miscellaneous Commercial ServicesCommercial Services Xenva Ltd. provides boutique management services. The company was founded on June 19, 1997 and is headquartered in Hampshire, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Evgen Ltd.
![]() Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Celltech Group Ltd.
![]() Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Financial Conglomerates | Corporate Officer/Principal | |
MedImmune Pharma BV
![]() MedImmune Pharma BV BiotechnologyHealth Technology MedImmune Pharma BV develops, manufactures and markets formulations for use in immunization programs. It specializes in the production of a vaccine called Amifostine. The company was founded in 1993 and is headquartered in Nijmegen, Belgium. | Biotechnology | Corporate Officer/Principal | |
BERGENBIO ASA | Pharmaceuticals: Major | Chairman | |
Oxford Ancestors Ltd.
![]() Oxford Ancestors Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Ancestors Ltd. provides portal engine and content management system. It offers maternal and paternal ancestry, genealogy services and database zone products. The company was founded by Bryan Clifford Sykes in 2000 and is headquartered in Bicester, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Tokamak Energy Ltd.
![]() Tokamak Energy Ltd. BiotechnologyHealth Technology Tokamak Energy Ltd. provides medical and biotechnology services. It develops the potential to use fusion neutrons for a variety of applications from material treatments to medical applications or low cost hydrogen production. The company was founded by David Richard Kingham, Mikhail Gryaznevich and Alan Sykes in 2009 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
Neurocentrx Pharma Ltd.
![]() Neurocentrx Pharma Ltd. Pharmaceuticals: MajorHealth Technology Neurocentrx Pharma Ltd. is a British pharmaceutical company that manufactures and distributes medicines. The company is based in Edinburgh, UK. Neurocentrx Pharma was founded by Howard Marriage, Ronald M. Lindsay, and Carmel Reilly. Carmel Reilly has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Founder | |
Butterfly Conservation
![]() Butterfly Conservation Miscellaneous Commercial ServicesCommercial Services Butterfly Conservation is a British charity that aims to save butterflies, moths, and their habitats. Butterfly Conservation has more than 40,000 members in the UK and 32 volunteer-run branches throughout the British Isles. The non-profit company is based in Wareham, UK. The organization operates 36 nature reserves and is leading or involved in 73 landscape-scale projects to conserve habitats. The organization employs over 80 people, including many highly qualified scientists, making it the world's largest research institute for butterflies and moths. Butterfly Conservation's new strategy sets out three key goals to drive forward their work, making a pledge for the impact they will make on threatened species, doubling their impact on landscape restoration, and involving people in transforming spaces for butterflies and moths. The British company was founded in 1968, and Julie Williams has been the CEO of the company since 2000. | Miscellaneous Commercial Services | Director/Board Member | |
Cascade Ltd.
![]() Cascade Ltd. Beverages: Non-AlcoholicConsumer Non-Durables Cascade Ltd. is a Belarusian company that produces a variety of non-alcoholic beverages, including carbonated soft drinks, flavored water, and mineral water. Cascade is based in Borisov, BY and offers job opportunities. The private company's products come in various sizes, ranging from 0.5 liters to 2.0 liters. The company emphasizes the health benefits of its products and encourages customers to maintain their body's water balance throughout the day. | Beverages: Non-Alcoholic | Director/Board Member | |
Cell Therapy Catapult Ltd.
![]() Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Cancer Research Campaign Technology Ltd. | Chief Executive Officer | ||
Newlands Court Management Co. Ltd. | Director/Board Member | ||
Spirogen SARL
![]() Spirogen SARL Pharmaceuticals: MajorHealth Technology Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin. | Pharmaceuticals: Major | Chief Executive Officer | |
Vectura Ltd.
![]() Vectura Ltd. Medical SpecialtiesHealth Technology Part of Philip Morris International, Inc., Vectura Ltd. is a leading inhalation CDMO that provides innovative inhaled drug development solutions to help bring medicines to market. The company is based in Chippenham, UK, and has planning permission for a new 10,000-square meter facility on Bristol & Bath Science Park - inhalation center of excellence. Vectura is reimagining healthcare and self-care, transforming the lives of airways disease patients. Founded in 1983, the British company specializes in formulation science, device technology, and inhaled development expertise to bring DPI, PMDI, and nebulizer medicines to market. | Medical Specialties | Director/Board Member | |
Osivax SAS
![]() Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
Tagworks Pharmaceuticals BV
![]() Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011. | Biotechnology | Chairman | |
Myricx Pharma Ltd.
![]() Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Qbiotics Group Ltd. | Director/Board Member | ||
Vectura GmbH
![]() Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 35 |
Svizzera | 4 |
Stati Uniti | 3 |
Paesi Bassi | 3 |
Germania | 3 |
Settori
Health Technology | 21 |
Commercial Services | 10 |
Health Services | 5 |
Finance | 5 |
Consumer Services | 4 |
Posizioni
Director/Board Member | 27 |
Chairman | 8 |
Corporate Officer/Principal | 7 |
Independent Dir/Board Member | 7 |
Chief Executive Officer | 6 |
Contatti più connessi
Insiders | |
---|---|
Susan Foden | 32 |
Christopher Martin | 18 |
- Borsa valori
- Insiders
- Ian Mark Buckley-Golder
- Connessioni Società